Insider Trading: ARS Pharmaceuticals' (NASDAQ:SPRY) Insiders Buy Shares Worth $679K

TipRanksApr 25 22:30

Market Sentiment Around Loss-Making ARS Pharmaceuticals, Inc. (NASDAQ:SPRY)

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. ARS Pharmaceuticals, Inc., a biopharmaceutica

Simply Wall StApr 22 19:50

ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing

Richard E Lowenthal, 10% Owner, Director, PRESIDENT AND CEO, on April 16, 2024, sold 100,000 shares in ARS Pharmaceuticals (SPRY) for $928,005. Following the Form 4 filing with the SEC, Lowenthal has

MT NewswiresApr 18 19:22

ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$928.01K in Common Stock

$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Lowenthal Richard E sold 100K shares of common stock on Apr 16, 2024 at an average price of $9.2801 for a total value of $928.01K. This transaction invol

Futu NewsApr 18 07:23

ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$927.73K in Common Stock

$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Lowenthal Richard E sold 100K shares of common stock on Apr 9, 2024 at an average price of $9.2773 for a total value of $927.73K. This transaction involv

Futu NewsApr 11 06:16

Ars Pharmaceuticals Insider Sold Shares Worth $927,735, According to a Recent SEC Filing

Richard E Lowenthal, 10% Owner, Director, President and CEO, on April 09, 2024, sold 100,000 shares in Ars Pharmaceuticals (SPRY) for $927,735. Following the Form 4 filing with the SEC, Lowenthal has

MT NewswiresApr 11 05:42